FDA: 1,279 facilities received other products from pharmacy linked to meningitis

By Lena H. Sun and Sarah Kliff, Published: October 22

Federal regulators are asking more than 1,200 hospitals, clinics and doctors nationwide to follow up with patients who may be at risk of infection because they received injectable medications made by the New England Compounding Center, a specialty pharmacy whose tainted steroid shots are linked to the growing fungal-meningitis outbreak.

In the Washington area, about 40 facilities, including several major hospitals and physician groups, are listed as having bought these injectable medications. Some said they were able to warn all affected patients about possible infection.

continue reading this article in Washington Post here